Published online Jul 7, 2021. doi: 10.3748/wjg.v27.i25.3901
Peer-review started: February 5, 2021
First decision: March 14, 2021
Revised: March 27, 2021
Accepted: May 21, 2021
Article in press: May 21, 2021
Published online: July 7, 2021
Processing time: 150 Days and 2.7 Hours
Globally, the proportion of young patients with colorectal cancer (CRC), especially in their 40s, is increasing, and this rate of increase is very rapid.
Patients with CRC in their 40s have the potential for both late-onset hereditary CRC and early-onset sporadic CRC. However, few studies have analyzed the characteristics of patients with CRC in their 40s.
The main aim of this study was to determine the proportion of patients with CRC in their 40s and to identify their clinical characteristics, especially compared with those in their 30s and 50s.
We compared patient and tumor characteristics as well as perioperative outcomes of patients in their 30s, 40s, and 50s who received primary resection for CRC. In addition, the 5-year survivals were compared between the three groups, excluding stage 4.
In patients with CRC in their 40s, there were significantly more metastatic lesions and a higher TNM stage. K-ras mutations tended to be low in patients in their 40s, and postoperative chemotherapy was frequently performed in them. Excluding stage 4, the 5-year overall and disease-free survivals of CRC patients in their 40s did not differ from those in their 30s and 50s.
Patients with CRC in their 40s exhibited relatively more metastatic lesions and a more advanced stage, but the oncologic outcomes of patients excluding stage 4 were not inferior compared to those in their 30s and 50s. Therefore, it is necessary to actively perform screening tests for early detection of CRC in those in their 40s.
More analyses of immunohistochemistry or genetic testing results are needed to complement our results. In addition, future studies are also needed to establish new standards for conducting genetic tests for patients with CRC in their 40s.